Systemic Autoimmune Rheumatic Disease Prevalence in Canada: Updated Analyses Across 7 Provinces

REFERENCES

1. 1.↵
   1. Callaghan R,
   2. Prabu A,
   3. Allan RB,
   4. Clarke AE,
   5. Sutcliffe N,
   6. Pierre YS,
   7. et al.

   Direct healthcare costs and predictors of costs in patients with primary Sjogren’s syndrome. Rheumatology 2007;46:105–11.

   OpenUrlAbstract/FREE Full Text
2. 2.↵
   1. Bernatsky S,
   2. Hudson M,
   3. Panopalis P,
   4. Clarke AE,
   5. Pope J,
   6. LeClercq S,
   7. et al.

   The cost of systemic sclerosis. Arthritis Rheum 2009;61:119–23.

   OpenUrlCrossRefPubMed
3. 3.↵
   1. Aghdassi E,
   2. Zhang W,
   3. St-Pierre Y,
   4. Clarke AE,
   5. Morrison S,
   6. Peeva V,
   7. et al.

   Healthcare cost and loss of productivity in a Canadian population of patients with and without lupus nephritis. J Rheumatol 2011;38:658–66.

   OpenUrlAbstract/FREE Full Text
4. 4.↵
   1. Panopalis P,
   2. Petri M,
   3. Manzi S,
   4. Isenberg DA,
   5. Gordon C,
   6. Senecal J-L,
   7. et al.

   The systemic lupus erythematosus tri-nation study: cumulative indirect costs. Arthritis Rheum 2007;57:64–70.

   OpenUrlCrossRefPubMed
5. 5.↵
   1. Hanly JG; and
   2. Canadian Council of Academic Rheumatologists

   . Manpower in Canadian academic rheumatology units: current status and future trends. J Rheumatol 2001;28:1944–51.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Bernatsky S,
   2. Lix L,
   3. Hanly JG,
   4. Hudson M,
   5. Badley E,
   6. Peschken C,
   7. et al.

   Surveillance of systemic autoimmune rheumatic diseases using administrative data. Rheumatol Int 2011;31:549–54.

   OpenUrlCrossRefPubMed
7. 7.↵
   1. Centers for Disease Control and Prevention

   . International Classification of Diseases, 10th revision, Clinical Modification (ICD-10-CM). [Internet. Accessed February 20, 2014.] Available from: www.cdc.gov/nchs/icd/icd10cm.htm
8. 8.↵
   1. Bernatsky S,
   2. Joseph L,
   3. Pineau CA,
   4. Belisle P,
   5. Boivin JF,
   6. Banerjee D,
   7. et al.

   Estimating the prevalence of polymyositis and dermatomyositis from administrative data: age, sex and regional differences. Ann Rheum Dis 2008;68:1192–6.

   OpenUrlPubMed
9. 9.↵
   1. Joseph L,
   2. Gyorkos TW,
   3. Coupal L

   . Bayesian-estimation of disease prevalence and the paramaters of diagnostic-tests in the absence of a gold standard. Am J Epidemiol 1995;141:263–72.

   OpenUrlAbstract/FREE Full Text
10. 10.↵
    1. Ashby D

    . Bayesian statistics in medicine: a 25 year review. Stat Med 2006;25:3589–631.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. Dendukuri N,
    2. Joseph L

    . Bayesian approaches to modeling the conditional dependence between multiple diagnostic tests. Biometrics 2001;57:158–67.

    OpenUrlCrossRefPubMed
12. 12.↵
    1. Vacek PM

    . The effect of conditional dependence on the evaluation of diagnostic-tests. Biometrics 1985;41:959–68.

    OpenUrlCrossRefPubMed
13. 13.↵
    1. Losina E,
    2. Barrett J,
    3. Baron JA,
    4. Katz JN

    . Accuracy of Medicare claims data for rheumatologic diagnoses in total hip replacement recipients. J Clin Epidemiol 2003;56:515–9.

    OpenUrlCrossRefPubMed
14. 14.↵
    1. Bernatsky S,
    2. Joseph L,
    3. Pineau CA,
    4. Tamblyn R,
    5. Feldman DE,
    6. Clarke AE

    . A population-based assessment of systemic lupus erythematosus incidence and prevalence results and implications of using administrative data for epidemiological studies. Rheumatology 2007;46:1814–8.

    OpenUrlAbstract/FREE Full Text
15. 15.↵
    1. Bernatsky S,
    2. Joseph L,
    3. Belisle P,
    4. Boivin JF,
    5. Rajan R,
    6. Moore A,
    7. et al.

    Bayesian modelling of imperfect ascertainment methods in cancer studies. Stat Med 2005;24:2365–79.

    OpenUrlCrossRefPubMed
16. 16.↵
    1. Ladouceur M,
    2. Rahme E,
    3. Pineau CA,
    4. Joseph L

    . Robustness of prevalence estimates derived from misclassified data from administrative databases. Biometrics 2007;63:272–9.

    OpenUrlCrossRefPubMed
17. 17.↵
    1. Statistics Canada

    . Geographic units: Census Metropolitan Area (CMA) and Census Agglomeration (CA). 2002. [Internet. Accessed February 20, 2014.] Available from: www12.statcan.ca/English/census01/Products/Reference/dict/geo009.htm
18. 18.↵
    1. Helmick CG,
    2. Felson DT,
    3. Lawrence RC,
    4. Gabriel S,
    5. Hirsch R,
    6. Kwoh CK,
    7. et al.

    Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Arthritis Rheum 2008;58:15–25.

    OpenUrlCrossRefPubMed
19. 19.↵
    1. Kabasakal Y,
    2. Kitapcioglu G,
    3. Turk T,
    4. Oder G,
    5. Durusoy R,
    6. Mete N,
    7. et al.

    The prevalence of Sjogren’s syndrome in adult women. Scand J Rheumatol 2006;35:379–83.

    OpenUrlCrossRefPubMed
20. 20.↵
    1. Rourke J

    . In search of a definition of “rural”. Can J Rural Med 1997;2:113–7.

    OpenUrl
21. 21.↵
    1. Statistics Canada

    . Aboriginal identity population by province and territory (2006 Census). [Internet. Accessed February 20, 2014.] Available from: www.statcan.gc.ca/tables-tableaux/sum-som/l01/cst01/demo60a-eng.htm
22. 22.↵
    1. Lindsay C

    . The Chinese community in Canada. [Internet. Accessed February 11, 2014.] Available from: www.statcan.gc.ca/pub/89-621-x/89-621-x2006001-eng.pdf
23. 23.↵
    1. Hopkinson ND,
    2. Doherty M,
    3. Powell RJ

    . Clinical features and race-specific incidence/prevalence rates of systemic lupus erythematosus in a geographically complete cohort of patients. Ann Rheum Dis 1994;53:675–80.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Samanta A,
    2. Feehally J,
    3. Roy S,
    4. Nichol FE,
    5. Sheldon PJ,
    6. Walls J

    . High prevalence of systemic disease and mortality in Asian subjects with systemic lupus erythematosus. Ann Rheum Dis 1991;50:490–2.

    OpenUrlAbstract/FREE Full Text
25. 25.↵
    1. Shapira Y,
    2. Agmon-Levin N,
    3. Shoenfeld Y

    . Geoepidemiology of autoimmune rheumatic diseases. Nat Rev Rheumatol 2010; 6:468–76.

    OpenUrlCrossRefPubMed
26. 26.↵
    1. Statistics Canada

    . Age and sex structure: Canada, provinces and territories. [Internet. Accessed February 20, 2014.] Available from: www.statcan.gc.ca/pub/91-215-x/2012000/part-partie2-eng.htm
27. 27.↵
    1. Ng R,
    2. Bernatsky S,
    3. Rahme E

    . Observation period effects on estimation of systemic lupus erythematosus incidence and prevalence in Quebec. J Rheumatol 2013;40:1334–6.

    OpenUrlAbstract/FREE Full Text
28. 28.↵
    1. Canadian Medical Association

    . Physicians by province/territory and specialty, Canada. 2012. [Internet. Accessed February 20, 2014.] Available from: www.cma.ca/multimedia/CMA/Content_Images/Inside_cma/Statistics/01Spec&Prov.pdf
29. 29.↵
    1. Canadian Institute for Health Information

    . Physicians in Canada: The status of alternative payment programs. [Internet. Accessed February 20, 2014.] Available from: https://secure.cihi.ca/estore/productSeries.htm?pc=PCC47
30. 30.↵
    1. Bernatsky S,
    2. Linehan T,
    3. Hanly JG

    . The accuracy of administrative data diagnoses of systemic autoimmune rheumatic diseases. J Rheumatol 2011;38:1612–6.

    OpenUrlAbstract/FREE Full Text
31. 31.↵
    1. Robitaille C,
    2. Dai S,
    3. Waters C,
    4. Loukine L,
    5. Bancej C,
    6. Quach S,
    7. et al.

    Diagnosed hypertension in Canada: incidence, prevalence and associated mortality. CMAJ 2012;184:E49–56.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Marrie RA,
    2. Yu BN,
    3. Leung S,
    4. Elliott L,
    5. Caetano P,
    6. Warren S,
    7. et al.

    Rising prevalence of vascular comorbidities in multiple sclerosis: validation of administrative definitions for diabetes, hypertension, and hyperlipidemia. Mult Scler 2012;18:1310–9.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Canadian Medical Association

    . Statistical information on Canadian physicians. 2009. [Internet. Accessed February 11, 2014.] Available from: www.cma.ca/index.cfm/ci_id/16959/la_id/1.htm
34. 34.↵
    1. Barnabe C,
    2. Joseph L,
    3. Bélisle P,
    4. Labrecque J,
    5. Barr SG,
    6. Fritzler MJ,
    7. et al.

    Prevalence of autoimmune inflammatory myopathy in the first nations population of Alberta, Canada. Arthritis Care Res 2012;64:1715–9.

    OpenUrlCrossRef
35. 35.↵
    1. Barnabe C,
    2. Joseph L,
    3. Bélisle P,
    4. Labrecque J,
    5. Edworthy S,
    6. Barr SG,
    7. et al.

    Prevalence of systemic lupus erythematosus and systemic sclerosis in the First Nations population of Alberta, Canada. Arthritis Care Res 2012;64:138–43.

    OpenUrlCrossRef
36. 36.↵
    1. Yiannakoulias N,
    2. Svenson LW,
    3. Schopflocher DP

    . An integrated framework for the geographic surveillance of chronic disease. Int J Health Geogr 2009;8:69.

    OpenUrlCrossRefPubMed